Abbott plans €85m investment in Irish facility
February 13, 2012Manufacturing and Production Abbott. IDA, Ireland, Xinlay
Abbott Laboratories has said it will invest around €85 million in its manufacturing facility in Sligo, Ireland, more than doubling …
Excipient certification scheme launches
February 13, 2012Manufacturing and Production EXCiPACT, GDP, GMP, manufacturing
A consortium of industry associations has launched a certification scheme for pharmaceutical excipients to make it easier for drugmakers to …
Pharma manufacturing news in brief
February 13, 2012Manufacturing and Production Bosch, Lilly/Bend Research, Neuland, OctoPlus Ferring and CHEMO Particle Sciences
Neuland posts revenue gains, Bosch buys Eisi machinery, plus deals for Lilly/Bend Research, OctoPlus/Ferring and CHEMO/Particle Sciences.
Carlyle Ware joins the Fishawack Group
February 13, 2012Business Services, Medical Communications, Sales and Marketing Fishawack Group, PR, fishawack
Med comms specialist the Fishawack Group has appointed Carlyle Ware as its group commercial director. Ware has over 13 years’ …
NHS productivity not declining: Lancet study
February 13, 2012Sales and Marketing Lancet, Lansley, NHS reform
A new study by the Lancet has shown that productivity in the NHS has improved over the past ten years. …
SHL takes part in PharmTech.com’s “Pointed Debate: Expert Views on Injectables”
February 13, 2012Manufacturing and Production auto injector, auto-injector, pen injector, shl group
SHL recently had the opportunity to participate along with various other experts in the industry in a questionnaire held by …
Quintiles launches new Asian market service
February 13, 2012Research and Development Asia, Quintiles, emerging markets
Contract research and consulting firm Quintiles has launched two new services to help pharma improve their chances of developing and …
FDA grants Roche’s pertuzumab priority review
February 10, 2012Sales and Marketing Herceptin, Roche, pertuzumab
The FDA has accepted Roche’s potential breast cancer treatment pertuzumab for appraisal and granted the drug priority review. The proposed …
Lundbeck appoints European leaders
February 10, 2012Medical Communications, Sales and Marketing Cipralex, Lundbeck
Lundbeck has appointed two new regional vice presidents for European markets, in time for new drug launches.João Rocha is to …
PR agencies warn of ‘race to the bottom’
February 10, 2012Medical Communications HCA, PR
A new survey of PR agencies working in healthcare has highlighted concerns about cost-cutting which they say could lower standards …
Value destruction: pharma has only itself to blame
February 10, 2012R&D productivity
Pharma has only itself to blame for destroying value from its R&D pipeline, according to Andrew Baum, managing director of …
MPs support health and social care integration
February 10, 2012Sales and Marketing NHS, social care
The integration of care services will help improve outcomes for older people and those with disabilities and long-term conditions, according …
Oxford BioMedica makes management change
February 10, 2012Research and Development, Sales and Marketing Oxford BioMedica
Gene-based biopharmaceutical firm Oxford BioMedica has announced that Andrew Wood, chief financial officer, has stepped down from the board of Oxford …
Chiltern welcomes Gastroenterology, Oncology and Pediatric Therapeutic experts to their team
February 9, 2012Research and Development
Chiltern International Limited (Chiltern), a global contract research organization (CRO), announced that Drs. Marcelo Piccirillo and Carlo Lanza have joined …
Doctors, medical education and pharma – the way ahead
February 9, 2012Medical Communications ABPI, ASME, CME, Continuing medical education, GMC, MEP
InPharm CME event Roy Pounder, Andrew Powrie-Smith, Richard Marchant, Roy Lilley, Kieran Walsh and Chuka Nwokolo are all speakers at …
European Medicines Agency and European Food Safety Authority commit to a stronger collaboration
February 9, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
The European Medicines Agency (EMA) and the European Food Safety Authority (EFSA) have agreed to work closer together on areas …
Bayer UK/Ireland appoints new chief financial officer
February 9, 2012Business Services, Sales and Marketing Bayer, Ute Bockstegers
Bayer has appointed Ms Ute Bockstegers as chief financial officer and head of business administration and partnering.Ute Bockstegers comes to …
Fate of Merck’s vorapaxar still unclear
February 8, 2012Medical Communications, Sales and Marketing Merck, vorapaxar
Merck & Co’s blood thinner vorapaxar, designed to prevent blood clots and reduce heart attacks, is still causing bleeding in …
New drug discounts should be made transparent
February 8, 2012Medical Communications, Sales and Marketing ABPI, NHS, NICE, access scheme, pricing
Patient access schemes agreed through NICE should be made more transparent. This is according to Paul McManus, a pharmacist and …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
